Silicon Laboratories (NASDAQ:SLAB) Expected to Post Quarterly Sales of $222.18 Million

Share on StockTwits

Analysts forecast that Silicon Laboratories (NASDAQ:SLAB) will announce $222.18 million in sales for the current quarter, Zacks reports. Four analysts have made estimates for Silicon Laboratories’ earnings, with estimates ranging from $222.00 million to $222.50 million. Silicon Laboratories reported sales of $215.53 million in the same quarter last year, which indicates a positive year-over-year growth rate of 3.1%. The company is expected to announce its next earnings report on Wednesday, January 29th.

According to Zacks, analysts expect that Silicon Laboratories will report full-year sales of $837.55 million for the current fiscal year, with estimates ranging from $831.80 million to $840.34 million. For the next fiscal year, analysts anticipate that the business will report sales of $917.06 million, with estimates ranging from $907.40 million to $926.41 million. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for Silicon Laboratories.

Silicon Laboratories (NASDAQ:SLAB) last released its quarterly earnings results on Wednesday, October 23rd. The semiconductor company reported $0.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.84 by $0.12. Silicon Laboratories had a net margin of 2.96% and a return on equity of 9.33%. The firm had revenue of $223.30 million for the quarter, compared to the consensus estimate of $217.97 million. During the same quarter in the previous year, the firm posted $1.01 EPS. The firm’s quarterly revenue was down 3.0% on a year-over-year basis.

SLAB has been the topic of several analyst reports. BidaskClub downgraded shares of Silicon Laboratories from a “hold” rating to a “sell” rating in a research note on Thursday, November 21st. Zacks Investment Research raised shares of Silicon Laboratories from a “sell” rating to a “hold” rating in a research note on Friday, October 25th. ValuEngine downgraded shares of Silicon Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. TheStreet raised shares of Silicon Laboratories from a “c+” rating to a “b-” rating in a research report on Wednesday, October 23rd. Finally, Needham & Company LLC reissued a “hold” rating on shares of Silicon Laboratories in a research report on Thursday, October 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $113.38.

Silicon Laboratories stock traded down $0.25 during midday trading on Wednesday, hitting $108.39. 181,737 shares of the stock were exchanged, compared to its average volume of 300,958. Silicon Laboratories has a 1 year low of $73.13 and a 1 year high of $115.29. The firm has a market cap of $4.49 billion, a P/E ratio of 37.90, a P/E/G ratio of 2.92 and a beta of 1.49. The company has a debt-to-equity ratio of 0.34, a current ratio of 6.78 and a quick ratio of 6.24. The company has a 50 day moving average price of $108.60 and a two-hundred day moving average price of $105.42.

In other news, Director William G. Bock sold 1,000 shares of Silicon Laboratories stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $109.84, for a total value of $109,840.00. Following the completion of the transaction, the director now directly owns 37,791 shares of the company’s stock, valued at approximately $4,150,963.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO John C. Hollister sold 10,000 shares of Silicon Laboratories stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $110.00, for a total transaction of $1,100,000.00. Following the completion of the transaction, the chief financial officer now directly owns 69,423 shares of the company’s stock, valued at $7,636,530. The disclosure for this sale can be found here. Insiders sold a total of 49,013 shares of company stock valued at $5,500,787 in the last three months. Insiders own 2.10% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Quest Capital Management Inc. ADV acquired a new position in Silicon Laboratories during the 3rd quarter valued at about $39,000. NumerixS Investment Technologies Inc acquired a new position in Silicon Laboratories during the 2nd quarter valued at about $93,000. Tower Research Capital LLC TRC boosted its stake in Silicon Laboratories by 832.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 998 shares of the semiconductor company’s stock valued at $104,000 after purchasing an additional 891 shares during the period. Sun Life Financial INC acquired a new position in Silicon Laboratories during the 2nd quarter valued at about $117,000. Finally, Ladenburg Thalmann Financial Services Inc. boosted its stake in Silicon Laboratories by 23.5% during the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,499 shares of the semiconductor company’s stock valued at $155,000 after purchasing an additional 285 shares during the period. 94.70% of the stock is owned by institutional investors and hedge funds.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, designs, develops, and markets mixed-signal integrated circuits (ICs) in the United States, China, and internationally. The company offers Internet of things products, including 8-bit mixed-signal, 32-bit wireless, and ultra-low-power 32-bit microcontrollers; wireless connectivity devices, such as multiprotocol wireless Gecko system-on-chip devices; real-time operating systems; sensor products comprising optical, relative humidity/temperature, and hall effect magnetic sensors.

Read More: 52 Week Highs

Get a free copy of the Zacks research report on Silicon Laboratories (SLAB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.